Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Which Factors Predict the Outcome of Radioactive Iodine Therapy of Graves’ Disease?
source: Clinical Thyroidology for the Public
year: 2019
summary/abstract:Graves’ disease is the most common cause of hyperthyroidism in the United States. Graves’ disease can be treated with medication (anti-thyroid drugs), surgery or radioactive iodine therapy. While the idealistic aim for treatment is to leave the patient with normal thyroid function long term, this is difficult to attain. In Europe and Asia, anti-thyroid drugs are frequently used as a first choice treatment.
However, many patients will have a relapse of their hyperthyroidism after a course of anti-thyroid drugs. Because of this, in the US, many patients are treated with a goal of destroying the thyroid with radioactive iodine therapy, leaving the patient with stable hypothyroidism and using thyroid hormone as a replacement.
Radioactive iodine therapy has become less popular recently with more patients started on antithyroid drugs. Since many people still feel that radioactive iodine therapy is a good treatment for hyperthyroidism, this study was done to review the response to radioactive iodine therapy as an initial treatment for Graves’ disease, including its’ usefulness and side effects.
read more
Related Content
-
Predictive Score for the Development or Progression of Graves’ Orbitopathy in Patients With Newly Diagnosed Gr...Objective: To construct a predictive sc...
-
Graves’ Disease Pharmacotherapy in Women of Reproductive AgeGraves' disease is an autoimmune disorde...
-
Genetic Associations of the Thyroid Stimulating Hormone Receptor Gene With Graves’ Diseases and Graves’ ...Graves' disease (GD) is a common thyroid...
-
Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients...Context: Recent evidence suggests thyro...
-
TSH-Receptor Autoimmunity in Graves’ Disease After Therapy With Anti-Thyroid Drugs, Surgery, or Radioiodine: A...Introduction: Autoimmunity against the ...
-
Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves HyperthyroidismContext: Supplemental selenium (Se) may...
-
The Second Antithyroid Drug Treatment is Effective in Relapsed Graves’ Disease Patients: A Median 11-Year Foll...Background: Antithyroid drug (ATD) is a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.